Cargando…
The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
Splicing abnormality resulting from somatic mutations in key splicing factor genes (SFG) has been detected in various cancers. Hence, an in-depth study of splicing factor genes mutations’ impact on pan-cancer is meaningful. This study investigated associations of splicing factor genes mutations with...
Autores principales: | Luo, Jiangti, Chen, Canping, Liu, Zhixian, Wang, Xiaosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852835/ https://www.ncbi.nlm.nih.gov/pubmed/36684432 http://dx.doi.org/10.3389/fcell.2022.1045130 |
Ejemplares similares
-
Pan-Cancer Analysis Reveals That E1A Binding Protein p300 Mutations Increase Genome Instability and Antitumor Immunity
por: Chen, Zuobing, et al.
Publicado: (2021) -
The spliceosome pathway activity correlates with reduced anti-tumor immunity and immunotherapy response, and unfavorable clinical outcomes in pan-cancer
por: Chen, Zuobing, et al.
Publicado: (2021) -
Upregulated ENC1 predicts unfavorable prognosis and correlates with immune infiltration in endometrial cancer
por: He, Lingling, et al.
Publicado: (2022) -
AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer
por: Wu, Gujie, et al.
Publicado: (2022) -
The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022)